Taking The Pulse Of The Texas Technology Industry |
|
Friday, March 17, 2017 Peloton Therapeutics Adds $22.2M Dallas-based cancer therapy developer Peloton Therapeutics said this week that it has raised $22.2M in its Series D funding, bringing the round to $74.6M. Source of the additional funding was not announced. Peloton Therapeutics had earlier announced $52.4M in a close on its Series D funding. The company is developing small molecule cancer therapy. Pelton is led by CEO John A. Josey, Ph.D. The earlier Series D tranche came from Foresite Capit (More info...) posted on Friday, March 17, 2017 (More)(Full story) Q2 Rolls Out New Fraud Screening Software Austin-based digital banking software developer Q2 Holdings announced a new software product this week, called Q2 Patrol, which it says helps financial institutions detect high-risk non-transactional fraudulent activity. Pricing on the new software was not announced. Q2 said the new product uses machine learning to identify potentially fraudulent digital banking sessions, using such information as past login behavior and device details, inclu (More info...) posted on Friday, March 17, 2017(Full story) |
|